Crazy1 personal page - To The Moon

Crazy1

Crazy1

No personal profile

6Follow

1Followers

0Topic

0Badge

2022-02-17

$Palantir Technologies Inc.(PLTR)$ why drop?

2021-06-18

$SK Target(08427)$What happened

2023-08-01

$Adamis Pharmaceuticals(ADMP)$ why suspension?

03-28

$Akebia Therapeutics(AKBA)$ Finally FDA approved

2022-03-22

$Akebia Therapeutics(AKBA)$will it move up [Cry]

2021-05-25

$FUSEN PHARM(01652)$What happen to Fusen

2021-04-06

$Iterum Therapeutics Plc(ITRM)$very good

04-29

$X4 Pharmaceuticals Inc(XFOR)$ what happen after FDA approval?

2023-05-23

$Cidara Therapeutics(CDTX)$ next stop 1.60?

2022-04-20

What happened, dropped so much

@yongjie1995:$Direxion Daily FTSE China bull 3x Shares(YINN)$Good

2021-04-09

Yes, should buy now

BRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3569277328719883,"uuid":"3569277328719883","gmtCreate":1606183305500,"gmtModify":1618583333025,"name":"Crazy1","pinyin":"crazy1","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":6,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.22%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":300539064123608,"gmtCreate":1714393309891,"gmtModify":1714393312728,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/XFOR\">$X4 Pharmaceuticals Inc(XFOR)$ </a> what happen after FDA approval?","listText":"<a href=\"https://ttm.financial/S/XFOR\">$X4 Pharmaceuticals Inc(XFOR)$ </a> what happen after FDA approval?","text":"$X4 Pharmaceuticals Inc(XFOR)$ what happen after FDA approval?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/300539064123608","isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":289156344574200,"gmtCreate":1711629421048,"gmtModify":1711629424660,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$ </a> Finally FDA approved&nbsp;","listText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$ </a> Finally FDA approved&nbsp;","text":"$Akebia Therapeutics(AKBA)$ Finally FDA approved","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/289156344574200","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":204248564932768,"gmtCreate":1690898738355,"gmtModify":1690898741502,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ADMP\">$Adamis Pharmaceuticals(ADMP)$ &nbsp;</a>why suspension?","listText":"<a href=\"https://ttm.financial/S/ADMP\">$Adamis Pharmaceuticals(ADMP)$ &nbsp;</a>why suspension?","text":"$Adamis Pharmaceuticals(ADMP)$ why suspension?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/204248564932768","isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970453754,"gmtCreate":1684854346379,"gmtModify":1684854349543,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CDTX\">$Cidara Therapeutics(CDTX)$ &nbsp;</a>next stop 1.60?","listText":"<a href=\"https://ttm.financial/S/CDTX\">$Cidara Therapeutics(CDTX)$ &nbsp;</a>next stop 1.60?","text":"$Cidara Therapeutics(CDTX)$ next stop 1.60?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970453754","isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9086640853,"gmtCreate":1650454376558,"gmtModify":1676534727267,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"What happened,&nbsp; dropped so much","listText":"What happened,&nbsp; dropped so much","text":"What happened, dropped so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086640853","repostId":"9083111707","repostType":1,"repost":{"id":9083111707,"gmtCreate":1650078362563,"gmtModify":1676534643064,"author":{"id":"4094374921158100","authorId":"4094374921158100","authorIdStr":"4094374921158100","name":"yongjie1995","avatar":"https://static.tigerbbs.com/c14fe2894dce47516c35dd3e37ff9392","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094374921158100"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/YINN\">$Direxion Daily FTSE China bull 3x Shares(YINN)$</a>Good","listText":"<a href=\"https://ttm.financial/S/YINN\">$Direxion Daily FTSE China bull 3x Shares(YINN)$</a>Good","text":"$Direxion Daily FTSE China bull 3x Shares(YINN)$Good","images":[{"img":"https://community-static.tradeup.com/news/e728032f8dc8920f3dcc70e94b5ad7ff","width":"1125","height":"2976"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083111707","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9034794087,"gmtCreate":1647960736033,"gmtModify":1676534285273,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$</a>will it move up&nbsp;[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$</a>will it move up&nbsp;[Cry]&nbsp;","text":"$Akebia Therapeutics(AKBA)$will it move up [Cry]","images":[{"img":"https://community-static.tradeup.com/news/6de2f1b28beb13cf7cc83cb8fefd3641","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9034794087","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9094834314,"gmtCreate":1645107307240,"gmtModify":1676533997777,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"$Palantir Technologies Inc.(PLTR)$ why drop?","listText":"$Palantir Technologies Inc.(PLTR)$ why drop?","text":"$Palantir Technologies Inc.(PLTR)$ why drop?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094834314","isVote":1,"tweetType":1,"viewCount":1213,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4092219617501870","authorId":"4092219617501870","authorIdStr":"4092219617501870","name":"AlvinLKG","avatar":"https://static.tigerbbs.com/fa5c83418b861a0ecfca2838331e8dea","crmLevel":2,"crmLevelSwitch":1,"idStr":"4092219617501870"},"content":"because eps no under expectations","text":"because eps no under expectations","html":"because eps no under expectations"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166123811,"gmtCreate":1623997580233,"gmtModify":1703826119639,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/08427\">$SK Target(08427)$</a>What happened&nbsp;","listText":"<a href=\"https://laohu8.com/S/08427\">$SK Target(08427)$</a>What happened&nbsp;","text":"$SK Target(08427)$What happened","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166123811","isVote":1,"tweetType":1,"viewCount":591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138144669,"gmtCreate":1621920866151,"gmtModify":1704364481133,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01652\">$FUSEN PHARM(01652)$</a>What happen to Fusen","listText":"<a href=\"https://laohu8.com/S/01652\">$FUSEN PHARM(01652)$</a>What happen to Fusen","text":"$FUSEN PHARM(01652)$What happen to Fusen","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/138144669","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346058284,"gmtCreate":1617976451548,"gmtModify":1704705548643,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"Yes, should buy now","listText":"Yes, should buy now","text":"Yes, should buy now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346058284","repostId":"2126608296","repostType":2,"repost":{"id":"2126608296","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617968516,"share":"https://ttm.financial/m/news/2126608296?lang=&edition=fundamental","pubTime":"2021-04-09 19:41","market":"us","language":"en","title":"BRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2126608296","media":"Reuters","summary":"April 9 (Reuters) - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT F","content":"<html><body><p>April 9 (Reuters) - Iterum Therapeutics <a href=\"https://laohu8.com/S/PLC\">PLC</a>   :</p><p>   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID</p><p>   * ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED</p><p>   * ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED</p><p>   * ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEW</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-09 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>April 9 (Reuters) - Iterum Therapeutics <a href=\"https://laohu8.com/S/PLC\">PLC</a>   :</p><p>   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID</p><p>   * ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED</p><p>   * ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED</p><p>   * ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEW</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ITRM":"Iterum Therapeutics Plc"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126608296","content_text":"April 9 (Reuters) - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID   * ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED   * ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED   * ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEWSource text for Eikon: [ Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":343258214,"gmtCreate":1617720289138,"gmtModify":1704702275518,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ITRM\">$Iterum Therapeutics Plc(ITRM)$</a>very good","listText":"<a href=\"https://laohu8.com/S/ITRM\">$Iterum Therapeutics Plc(ITRM)$</a>very good","text":"$Iterum Therapeutics Plc(ITRM)$very good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/343258214","isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9094834314,"gmtCreate":1645107307240,"gmtModify":1676533997777,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"$Palantir Technologies Inc.(PLTR)$ why drop?","listText":"$Palantir Technologies Inc.(PLTR)$ why drop?","text":"$Palantir Technologies Inc.(PLTR)$ why drop?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094834314","isVote":1,"tweetType":1,"viewCount":1213,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4092219617501870","authorId":"4092219617501870","authorIdStr":"4092219617501870","name":"AlvinLKG","avatar":"https://static.tigerbbs.com/fa5c83418b861a0ecfca2838331e8dea","crmLevel":2,"crmLevelSwitch":1,"idStr":"4092219617501870"},"content":"because eps no under expectations","text":"because eps no under expectations","html":"because eps no under expectations"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166123811,"gmtCreate":1623997580233,"gmtModify":1703826119639,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/08427\">$SK Target(08427)$</a>What happened&nbsp;","listText":"<a href=\"https://laohu8.com/S/08427\">$SK Target(08427)$</a>What happened&nbsp;","text":"$SK Target(08427)$What happened","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166123811","isVote":1,"tweetType":1,"viewCount":591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":204248564932768,"gmtCreate":1690898738355,"gmtModify":1690898741502,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/ADMP\">$Adamis Pharmaceuticals(ADMP)$ &nbsp;</a>why suspension?","listText":"<a href=\"https://ttm.financial/S/ADMP\">$Adamis Pharmaceuticals(ADMP)$ &nbsp;</a>why suspension?","text":"$Adamis Pharmaceuticals(ADMP)$ why suspension?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/204248564932768","isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":289156344574200,"gmtCreate":1711629421048,"gmtModify":1711629424660,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$ </a> Finally FDA approved&nbsp;","listText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$ </a> Finally FDA approved&nbsp;","text":"$Akebia Therapeutics(AKBA)$ Finally FDA approved","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/289156344574200","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9034794087,"gmtCreate":1647960736033,"gmtModify":1676534285273,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$</a>will it move up&nbsp;[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/AKBA\">$Akebia Therapeutics(AKBA)$</a>will it move up&nbsp;[Cry]&nbsp;","text":"$Akebia Therapeutics(AKBA)$will it move up [Cry]","images":[{"img":"https://community-static.tradeup.com/news/6de2f1b28beb13cf7cc83cb8fefd3641","width":"720","height":"1280"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9034794087","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":138144669,"gmtCreate":1621920866151,"gmtModify":1704364481133,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01652\">$FUSEN PHARM(01652)$</a>What happen to Fusen","listText":"<a href=\"https://laohu8.com/S/01652\">$FUSEN PHARM(01652)$</a>What happen to Fusen","text":"$FUSEN PHARM(01652)$What happen to Fusen","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/138144669","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":343258214,"gmtCreate":1617720289138,"gmtModify":1704702275518,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ITRM\">$Iterum Therapeutics Plc(ITRM)$</a>very good","listText":"<a href=\"https://laohu8.com/S/ITRM\">$Iterum Therapeutics Plc(ITRM)$</a>very good","text":"$Iterum Therapeutics Plc(ITRM)$very good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/343258214","isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":300539064123608,"gmtCreate":1714393309891,"gmtModify":1714393312728,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/XFOR\">$X4 Pharmaceuticals Inc(XFOR)$ </a> what happen after FDA approval?","listText":"<a href=\"https://ttm.financial/S/XFOR\">$X4 Pharmaceuticals Inc(XFOR)$ </a> what happen after FDA approval?","text":"$X4 Pharmaceuticals Inc(XFOR)$ what happen after FDA approval?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/300539064123608","isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970453754,"gmtCreate":1684854346379,"gmtModify":1684854349543,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CDTX\">$Cidara Therapeutics(CDTX)$ &nbsp;</a>next stop 1.60?","listText":"<a href=\"https://ttm.financial/S/CDTX\">$Cidara Therapeutics(CDTX)$ &nbsp;</a>next stop 1.60?","text":"$Cidara Therapeutics(CDTX)$ next stop 1.60?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970453754","isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9086640853,"gmtCreate":1650454376558,"gmtModify":1676534727267,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"What happened,&nbsp; dropped so much","listText":"What happened,&nbsp; dropped so much","text":"What happened, dropped so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9086640853","repostId":"9083111707","repostType":1,"repost":{"id":9083111707,"gmtCreate":1650078362563,"gmtModify":1676534643064,"author":{"id":"4094374921158100","authorId":"4094374921158100","authorIdStr":"4094374921158100","name":"yongjie1995","avatar":"https://static.tigerbbs.com/c14fe2894dce47516c35dd3e37ff9392","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4094374921158100"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/YINN\">$Direxion Daily FTSE China bull 3x Shares(YINN)$</a>Good","listText":"<a href=\"https://ttm.financial/S/YINN\">$Direxion Daily FTSE China bull 3x Shares(YINN)$</a>Good","text":"$Direxion Daily FTSE China bull 3x Shares(YINN)$Good","images":[{"img":"https://community-static.tradeup.com/news/e728032f8dc8920f3dcc70e94b5ad7ff","width":"1125","height":"2976"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083111707","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":346058284,"gmtCreate":1617976451548,"gmtModify":1704705548643,"author":{"id":"3569277328719883","authorId":"3569277328719883","authorIdStr":"3569277328719883","name":"Crazy1","avatar":"https://static.tigerbbs.com/3c1331f1d332601a56a249658bed0619","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569277328719883"},"themes":[],"htmlText":"Yes, should buy now","listText":"Yes, should buy now","text":"Yes, should buy now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/346058284","repostId":"2126608296","repostType":2,"repost":{"id":"2126608296","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1617968516,"share":"https://ttm.financial/m/news/2126608296?lang=&edition=fundamental","pubTime":"2021-04-09 19:41","market":"us","language":"en","title":"BRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2126608296","media":"Reuters","summary":"April 9 (Reuters) - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT F","content":"<html><body><p>April 9 (Reuters) - Iterum Therapeutics <a href=\"https://laohu8.com/S/PLC\">PLC</a>   :</p><p>   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID</p><p>   * ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED</p><p>   * ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED</p><p>   * ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEW</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Iterum Therapeutics Says FDA Needs More Time To Review Materials Provided In Support Of NDA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-09 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>April 9 (Reuters) - Iterum Therapeutics <a href=\"https://laohu8.com/S/PLC\">PLC</a>   :</p><p>   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID</p><p>   * ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED</p><p>   * ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED</p><p>   * ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEW</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ITRM":"Iterum Therapeutics Plc"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2126608296","content_text":"April 9 (Reuters) - Iterum Therapeutics PLC   :   * ITERUM THERAPEUTICS - GOT NOTICE FROM FDA THAT FDA NEEDS MORE TIME TO REVIEW MATERIALS PROVIDED IN SUPPORT OF NDA FOR SULOPENEM ETZADROXIL/PROBENECID   * ITERUM THERAPEUTICS PLC - PREVIOUSLY SCHEDULED FDA ANTIMICROBIAL DRUGS ADVISORY COMMITTEE ON JUNE 2, 2021 HAS BEEN POSTPONED   * ITERUM THERAPEUTICS PLC - NEW DATE FOR FDA PANEL REVIEW OF COMPANY'S NDA HAS NOT YET BEEN CONFIRMED   * ITERUM THERAPEUTICS PLC - CONTINUES TO WORK CLOSELY WITH FDA TO FACILITATE ITS PANEL REVIEWSource text for Eikon: [ Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":311,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}